<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JACC Case Rep</journal-id><journal-id journal-id-type="iso-abbrev">JACC Case Rep</journal-id><journal-title-group><journal-title>JACC Case Reports</journal-title></journal-title-group><issn pub-type="epub">2666-0849</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39972705</article-id><article-id pub-id-type="pmc">PMC11861929</article-id><article-id pub-id-type="pii">S2666-0849(24)01016-7</article-id><article-id pub-id-type="doi">10.1016/j.jaccas.2024.102952</article-id><article-id pub-id-type="publisher-id">102952</article-id><article-categories><subj-group subj-group-type="heading"><subject>Coronary, Peripheral, and Structural Interventions</subject><subj-group><subject>Clinical Case</subject></subj-group></subj-group></article-categories><title-group><article-title>Rare Case of Early Mycotic Ascending Aortic Aneurysm Following Transcatheter Aortic Valve Replacement</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Sambyal</surname><given-names>Bharat S.</given-names></name><degrees>DM</degrees><email>drbharatsambyal@gmail.com</email><ext-link ext-link-type="uri" xlink:href="https://twitter.com/drbharatsambyal">@drbharatsambyal</ext-link><xref rid="aff1" ref-type="aff">a</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Patel</surname><given-names>Nitin</given-names></name><degrees>DM</degrees><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Panda</surname><given-names>Prashant</given-names></name><degrees>DM</degrees><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>Sharma</surname><given-names>Yash Paul</given-names></name><degrees>DM</degrees><xref rid="aff4" ref-type="aff">d</xref></contrib><aff id="aff1"><label>a</label>Department of Cardiology, Indian Naval Hospital Ship ASVINI, RC Church, Colaba, Mumbai</aff><aff id="aff2"><label>b</label>Department of Cardiology, Post Graduate Institute of Medical Education, Chandigarh, India</aff><aff id="aff3"><label>c</label>Department of Cardiology, Post Graduate Institute of Medical Education, Chandigarh, India</aff><aff id="aff4"><label>d</label>Department of Cardiology, Post Graduate Institute of Medical Education, Chandigarh, India</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label><bold>Address for correspondence:</bold> Dr Bharat S. Sambyal, Department of Cardiology, Indian Naval Hospital Ship ASVINI, RC Church, Colaba, Mumbai 400005, India. <email>drbharatsambyal@gmail.com</email><ext-link ext-link-type="uri" xlink:href="https://twitter.com/drbharatsambyal">@drbharatsambyal</ext-link></corresp></author-notes><pub-date pub-type="pmc-release"><day>19</day><month>2</month><year>2025</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><day>19</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>19</day><month>2</month><year>2025</year></pub-date><volume>30</volume><issue>4</issue><elocation-id>102952</elocation-id><history><date date-type="received"><day>4</day><month>9</month><year>2024</year></date><date date-type="rev-recd"><day>17</day><month>10</month><year>2024</year></date><date date-type="accepted"><day>28</day><month>10</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2025 The Authors</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract abstract-type="graphical" id="abs0010"><title>Graphical Abstract</title><fig id="undfig1" position="anchor"><graphic xlink:href="ga1"/></fig></abstract><abstract id="abs0015"><p>Prosthetic valve endocarditis, though a rare complication, carries a high risk of morbidity and mortality. Mycotic aneurysms are even less common and have been reported in association with femoral access (femoral artery aneurysms)&#x000a0;following transcatheter aortic valve replacement (TAVR). We describe a rare case of a mycotic aneurysm that developed in the ascending aorta after a TAVR procedure.</p></abstract><kwd-group id="kwrds9010"><title>Key Words</title><kwd>infective endocarditis</kwd><kwd>prosthetic valve endocarditis</kwd><kwd>thoracic aortic mycotic aneurysms</kwd><kwd>transcatheter aortic valve replacement</kwd></kwd-group></article-meta><def-list><title>Abbreviations and Acronyms</title><def-item><term id="kwrd0015">IE</term><def><p>infective endocarditis</p></def></def-item><def-item><term id="kwrd0025">PVE</term><def><p>prosthetic valve endocarditis</p></def></def-item><def-item><term id="kwrd0035">SAVR</term><def><p>surgical aortic valve replacement</p></def></def-item><def-item><term id="kwrd0045">TAVR</term><def><p>transcatheter aortic valve replacement</p></def></def-item></def-list></front><body><p id="p0010">
<boxed-text id="dtbox1"><sec id="dtbox1sec1"><title>Learning Objectives</title><p id="p0015">
<list list-type="simple" id="ulist0010"><list-item id="u0010"><label>&#x02022;</label><p id="p0020">To be aware of such rare complications of TAVR.</p></list-item><list-item id="u0015"><label>&#x02022;</label><p id="p0025">To understand the need for strict asepsis during such procedures</p></list-item><list-item id="u0020"><label>&#x02022;</label><p id="p0030">To demonstrate the feasibility of transthoracic and esophageal echo for diagnosing periprosthetic valvular mycotic aneurysms.</p></list-item></list>
</p></sec></boxed-text>
</p><p id="p0035">Approximately 10% to 30% of all infective endocarditis (IE) cases are prosthetic valve endocarditis (PVE), which occurs in 0.3% to 1.2% of patients who undergo a surgical aortic valve replacement (SAVR) every year. PVE can be very serious and cause death in up to 30% of cases. It can also damage the valve and lead to formation of abscesses, pseudoaneurysms, fistulas, perforations, heart blocks and stroke.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> Most studies on PVE have focused on SAVR, but now there is more interest in PVE after transcatheter aortic valve replacement (TAVR). The rate of PVE after TAVR is approximately between 0.6% and 3.4%.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> PVE after TAVR is different from PVE after SAVR because it has specific infection risks, which are related to access site and the fact that the procedure is performed outside a standard operating theater. Other factors that may increase the risk of infection are valve crimping injury, paravalvular leak turbulence, neoleaflet stress with misaligned commissures, intact versus calcified native leaflets, and intracardiac hardware such as pacemaker leads.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref><sup>,</sup><xref rid="bib5" ref-type="bibr"><sup>5</sup></xref></p><p id="p0040">PVE presenting as an aortic mycotic aneurysm is extremely rare. Approximately 5.9 out of every 100,000 people develop thoracic aortic aneurysms every year, making thoracic aortic mycotic aneurysms extremely rare.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> Panagides et&#x000a0;al<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> mention pseudoaneurysm in 7 patients out of 579 cases of definite IE, which itself makes it a rare occurrence. There are very few reports of thoracic aortic aneurysms after SAVR; however, there are no reported cases of thoracic aortic aneurysms after TAVR presenting as early PVE. The femoral artery can have mycotic aneurysms after TAVR. Mycotic aneurysms often cause vague symptoms and signs, such as fever, night sweats, high white blood cell count, increased inflammatory markers, sepsis, pain in the chest, difficulty in swallowing, cough, wheezing, stridor, and pneumonitis.<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> In order to diagnose and treat these patients early, a very high index of suspicion is needed. Mycotic aneurysms can easily rupture, leading to poor outcomes despite medical and surgical intervention.<xref rid="bib8" ref-type="bibr">8</xref>, <xref rid="bib9" ref-type="bibr">9</xref>, <xref rid="bib10" ref-type="bibr">10</xref> However, imaging-guided early diagnosis and antimicrobial therapy help to achieve better prognosis in these patients. Research has shown that most mycotic aneurysms (80%) are caused by microbial infection of the aorta and only a few (3%) are estimated to involve infection of an aneurysm that was already present.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref></p><sec id="sec1"><title>History of Presentation and Past Medical History</title><p id="p0045">A 67-year-old man with a history of being managed at a different hospital presented to our institution with complaints of chest pain, shortness of breath, and 1 episode of syncope and being managed for the same at a government hospital in North India approximately 6&#x000a0;months ago. There he was diagnosed with bicuspid aortic valve with severe aortic stenosis and he underwent TAVR with a 30-mm valve via femoral access at the same hospital in June 2021. After TAVR, the patient was asymptomatic and his left ventricular ejection fraction improved from 15% to 40%.</p><p id="p0050">Two months after the procedure, he presented with high-grade fever, anorexia, and weakness when blood cultures revealed <italic>Burkholderia</italic> septicemia and he was managed with antibiotics as per sensitivity pattern for 6&#x000a0;weeks (meropenem, vancomycin, and cotrimoxazole). Echocardiography was suggestive of mild aortic valvular thickening. After intravenous drug cessation, he again presented with recurrent fever. Further investigations revealing an aortic root abscess on the basis of echo findings of hyperechoic lesions with perivalvular thickening. Repeat blood culture revealed the growth of <italic>Stenotrophomonas melophilia</italic>. He was treated with antibiotics for approximately 1&#x000a0;month with only a partial response. Therefore, the patient came to our institute for further management on his own accord.</p></sec><sec id="sec2"><title>Investigations and Management</title><p id="p0055">At our institute, the patient presented with intermittent fever, cough, weakness and investigations suggested normocytic normochromic anemia, leukocytosis with a shift to the left and thrombocytopenia. Renal and liver function were normal.</p><p id="p0060">An electrocardiogram revealed sinus rhythm, left ventricular hypertrophy, left bundle branch block, and first-degree atrioventricular block (PR interval of 280&#x000a0;ms). A 2-dimensional transthoracic echocardiogram revealed heterogeneous hyperechoic lesion with perivalvular thickening and a peak aortic velocity of 2.1&#x000a0;m/s with peak gradient of 19mmHg. There was no clot or effusion. Transesophageal echocardiography (TEE) (<xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref>, <xref rid="mmc2" ref-type="supplementary-material">Videos 2</xref> and <xref rid="mmc3" ref-type="supplementary-material">3</xref>) revealed an aortic root abscess with normal prosthetic valve leaflets. Contrast-enhanced computed tomography of the thorax and abdomen revealed hepatosplenomegaly, a splenic infarct and a calcified nodule in the lung. Computed tomography angiography (<xref rid="fig2" ref-type="fig">Figures&#x000a0;2</xref> and <xref rid="fig3" ref-type="fig">3</xref>, <xref rid="mmc1" ref-type="supplementary-material">Video 1</xref>) revealed a mycotic ascending aortic aneurysm.<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Transesophageal Echocardiography Images</p><p>(A) A 4-chamber view showing prosthetic aortic valve (acoustic shadow of the valve struts seen) with perivalvular oval opacity with hypoechoic centre. (B) A more short axis view of the prosthetic valve with para valvular opacity (red arrow indicating the paravalvular lesion).</p></caption><graphic xlink:href="gr1"/></fig><fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Computed Tomography Scan</p><p>(A) Perivalvular mycotic aneurysm seen in aorta. (B) Axial section showing aortic mycotic aneurysm with a small neck (red arrow indicating the lesion).</p></caption><graphic xlink:href="gr2"/></fig><fig id="fig3"><label>Figure&#x000a0;3</label><caption><p>CT 3D Reconstruction of Aortic Root With the Prosthetic Valve</p><p>(A) Perivalvular mycotic aneurysm seen in aorta through the upper edge of valve (enface view). (B) Perivalvular mycotic aneurysm with a small neck (profile view); red arrow towards the aneurysm, yellow towards the upper edge of the prosthetic valve. See <xref rid="mmc1" ref-type="supplementary-material">Video 1</xref>.</p></caption><graphic xlink:href="gr3"/></fig></p><p id="p0065">Blood culture revealed <italic>Pseudomonas aeruginosa</italic>. The patient was managed with antibiotics according to the sensitivity pattern and needed supportive care for 4&#x000a0;weeks for hemodynamic stabilization. Although the details of previous culture were not available, the close relationship of previous isolates to <italic>Pseudomonas</italic> (<italic>Burkholderia</italic> and <italic>Stenotrophomonas melophilia</italic>; both nosocomial gram-negative previously classified to the <italic>Pseudomonas</italic> genus) and the site of the pseudoaneurysm (as noted on the 3-dimensional computed tomography) with presentation 2&#x000a0;months after the implant were highly suspicious of likely seeding of the valve during the process of implantation.</p><p id="p0070">The patient was further advised to undergo SAVR with aortic root replacement as a definitive treatment due to poor resolution of the root abscess and inflammatory markers. Despite repeated counselling by the treating team, the patient was unwilling to undergo surgical intervention and did not consent for further intervention. He was managed further with oral antibiotics and after being culture negative, was discharged against medical advice.</p></sec><sec id="sec3"><title>Discussion</title><p id="p0075">We report a rare case of thoracic aortic mycotic aneurysm after TAVR. Common micro-organisms that cause bacteremia during TAVR include staphylococci, streptococci and enterococci.<xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> The usual causative site for a femoral access is the groin. TAVR is performed through a small hole in the femoral artery instead of opening the chest during SAVR; thus, early PVE may be less common, but many specific factors related to TAVR can explain how it occurs. A prime consideration is how to clean the place where transcatheter procedures are performed.<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref><sup>,</sup><xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> However, many studies do not show a difference in the infection rates on the basis of where TAVR is performed in the hospital, and several other studies have shown similar results, when the procedure is performed at a lower cost in a normal catheterization laboratory.<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref><sup>,</sup><xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> Unfortunately, the emphasis on stringent infection control protocols is generally less pronounced in catheterization labs compared to operating rooms. Hubble et&#x000a0;al<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> studied 2 types of ventilation in procedural rooms and reported that, regardless of what sterile protective gear operators wore, positive pressure labs had more bacterias, as measured by colony forming units than laminar flow theaters did. Other risks are related to the TAVR procedure itself, such as crimping of valve leaflets when loading and inflating the valve, which can cause tiny cell damage that causes inflammation and bacterial colonization.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> Paravalvular leak can also be a source of infection due to turbulence between the transcatheter prosthesis and native valve, which increases platelet clumping and blood clot formation.<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> This aids bacterial seeding, as the sticky platelet&#x02013;fibrin environment is used by organisms to make the matrix of vegetation.</p><p id="p0080">PVE has been defined for TAVR in the Valve Academic Research Consortium-2 document as follows: fulfillment of the Duke criteria, evidence of abscess/paravalvular leak/pus/vegetation on reoperation, or the aforementioned findings during autopsy.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> PVE can be categorized as early (within 2&#x000a0;months), intermediate (between 2 and 12&#x000a0;months), or late (&#x0003e;12&#x000a0;months).<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref></p><p id="p0085">TEE is suggested for patients who have at least a possible IE according to clinical criteria or who have a complicated IE (ie, a paravalvular abscess). It should be performed again after 1&#x000a0;week if the results are not clear and there is a high risk. A negative TEE does not rule out PVE. With a negative TEE but high suspicion, other imaging modalities, including magnetic resonance imaging, leukocyte scanning, and 18F-fluorodeoxyglucose positron emission tomography/computed tomography. should be considered.<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> Treatment of TAVR PVE consists of antimicrobial therapy and surgical debridement, including graft excision.</p><p id="p0090">European guidelines for administrating antibiotics before TAVR/SAVR surgery include the administration of antibiotics (i.e., intravenous cefazolin) prior to access or incision. It is also suggested to screen and treat for <italic>Staph. aureus</italic> before the procedure (class I).<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref><sup>,</sup><xref rid="bib22" ref-type="bibr"><sup>22</sup></xref></p></sec><sec id="sec4"><title>Conclusions</title><p id="p0095">To summarize, post TAVR thoracic aortic mycotic aneurysm is a rare but a serious complication, with high rates of morbidity and death. Being young has always been a risk factor for PVE, which makes it important to understand its presentation and how to treat them according to guidelines for TAVR PVE, as the current indications are expanding to younger and lower-risk individuals. A team approach by a surgeon, cardiologist, and infectious disease specialist can help improve outcomes in these complicated patients.</p></sec><sec sec-type="COI-statement" id="coi0010"><title>Funding Support and Author Disclosures</title><p id="p0035a">The authors have reported that they have no relationships relevant to the contents of this paper to disclose.</p></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="book" id="sref1"><person-group person-group-type="author"><name><surname>Pettersson</surname><given-names>G.B.</given-names></name><name><surname>Hussain</surname><given-names>S.T.</given-names></name></person-group><part-title>Surgical treatment of aortic valve endocarditis</part-title><person-group person-group-type="editor"><name><surname>Cohn</surname><given-names>L.H.</given-names></name><name><surname>Adams</surname><given-names>D.H.</given-names></name></person-group><source>Cardiac surgery in the Adult</source><edition>5th ed.</edition><year>2018</year><publisher-name>McGraw-Hill Education</publisher-name><publisher-loc>New York</publisher-loc><fpage>731</fpage><lpage>741</lpage></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Amat-Santos</surname><given-names>I.J.</given-names></name><name><surname>Messika-Zeitoun</surname><given-names>D.</given-names></name><name><surname>Eltchaninoff</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry</article-title><source>Circulation</source><volume>131</volume><year>2015</year><fpage>1566</fpage><lpage>1574</lpage><pub-id pub-id-type="pmid">25753535</pub-id>
</element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>N.T.</given-names></name><name><surname>De Backer</surname><given-names>O.</given-names></name><name><surname>Thyregod</surname><given-names>H.G.H.</given-names></name><etal/></person-group><article-title>Prosthetic valve endocarditis after transcatheter aortic valve implantation</article-title><source>Circ Cardiovasc Interv</source><volume>8</volume><year>2015</year><object-id pub-id-type="publisher-id">e001939</object-id><pub-id pub-id-type="doi">10.1161/CIRCINTERVENTIONS.114.001939</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Kolte</surname><given-names>D.</given-names></name><name><surname>Goldsweig</surname><given-names>A.</given-names></name><name><surname>Kennedy</surname><given-names>K.F.</given-names></name><etal/></person-group><article-title>Comparison of incidence, predictors, and outcomes of early infective endocarditis after transcatheter aortic valve implantation versus surgical aortic valve replacement in the United States</article-title><source>Am J Cardiol</source><volume>122</volume><year>2018</year><fpage>2112</fpage><lpage>2119</lpage><pub-id pub-id-type="pmid">30292332</pub-id>
</element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Yeo</surname><given-names>I.</given-names></name><name><surname>Kim</surname><given-names>L.K.</given-names></name><name><surname>Park</surname><given-names>S.O.</given-names></name><name><surname>Wong</surname><given-names>S.C.</given-names></name></person-group><article-title>In-hospital infective endocarditis following transcatheter aortic valve replacement: a cross-sectional study of the National Inpatient Sample database in the USA</article-title><source>J&#x000a0;Hosp Infect</source><volume>100</volume><year>2018</year><fpage>444</fpage><lpage>450</lpage><pub-id pub-id-type="pmid">29803809</pub-id>
</element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="book" id="sref6"><person-group person-group-type="author"><name><surname>Brunicardi</surname><given-names>F.</given-names></name><name><surname>Anderson</surname><given-names>D.</given-names></name></person-group><part-title>Thoracic aneurysms and aortic dissection</part-title><source>Schwartz's principles of surgery</source><edition>9th ed.</edition><year>2010</year><publisher-name>McGraw-Hill, Health Professions Division</publisher-name><publisher-loc>New York</publisher-loc><fpage>668</fpage><lpage>669</lpage></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Panagides</surname><given-names>V.</given-names></name><name><surname>Del Val</surname><given-names>D.</given-names></name><name><surname>Abdel-Wahab</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Perivalvular extension of infective endocarditis after transcatheter aortic valve replacement</article-title><source>Clin Infect Dis</source><volume>75</volume><year>2022</year><fpage>638</fpage><lpage>646</lpage><pub-id pub-id-type="pmid">34894124</pub-id>
</element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Afsari</surname><given-names>K.</given-names></name><name><surname>Stallone</surname><given-names>R.</given-names></name><name><surname>Wong</surname><given-names>G.D.</given-names></name></person-group><article-title>Mycotic (infected) aneurysm caused by Streptococcus pneumoniae</article-title><source>Infect Med</source><volume>18</volume><issue>6</issue><year>2001</year></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>Y.C.</given-names></name><name><surname>Morales</surname><given-names>J.P.</given-names></name><name><surname>Taylor</surname><given-names>P.R.</given-names></name></person-group><article-title>The management of mycotic aortic aneurysms: is there a role for endoluminal treatment?</article-title><source>Acta Chir Belg</source><volume>105</volume><year>2005</year><fpage>580</fpage><lpage>587</lpage><pub-id pub-id-type="pmid">16438066</pub-id>
</element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Mitrev</surname><given-names>Z.K.</given-names></name><name><surname>Anguseva</surname><given-names>T.N.</given-names></name></person-group><article-title>Life-threatening surgery for mycotic aneurysm</article-title><source>Aorta</source><volume>1</volume><year>2013</year><fpage>193</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">26798693</pub-id>
</element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Laohapensang</surname><given-names>K.</given-names></name><name><surname>Rutherford</surname><given-names>R.B.</given-names></name><name><surname>Arworn</surname><given-names>S.</given-names></name></person-group><article-title>Infected aneurysm</article-title><source>Ann Vasc Dis</source><volume>3</volume><year>2010</year><fpage>16</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.3400/avd.ctiia09002</pub-id><pub-id pub-id-type="pmid">23555383</pub-id>
</element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Hubble</surname><given-names>M.J.</given-names></name><name><surname>Weale</surname><given-names>A.E.</given-names></name><name><surname>Perez</surname><given-names>J.V.</given-names></name><name><surname>Bowker</surname><given-names>K.E.</given-names></name><name><surname>MacGowan</surname><given-names>A.P.</given-names></name><name><surname>Bannister</surname><given-names>G.C.</given-names></name></person-group><article-title>Clothing in laminar-flow operating theatres</article-title><source>J&#x000a0;Hosp Infect</source><volume>32</volume><year>1996</year><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8904367</pub-id>
</element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Mylotte</surname><given-names>D.</given-names></name><name><surname>Andalib</surname><given-names>A.</given-names></name><name><surname>Theriault-Lauzier</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Transcatheter heart valve failure: a systematic review</article-title><source>Eur Heart J</source><volume>36</volume><year>2015</year><fpage>1306</fpage><lpage>1327</lpage><pub-id pub-id-type="pmid">25265974</pub-id>
</element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Babaliaros</surname><given-names>V.</given-names></name><name><surname>Devireddy</surname><given-names>C.</given-names></name><name><surname>Lerakis</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis</article-title><source>JACC Cardiovasc Interv</source><volume>7</volume><year>2014</year><fpage>898</fpage><lpage>904</lpage><pub-id pub-id-type="pmid">25086843</pub-id>
</element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Spaziano</surname><given-names>M.</given-names></name><name><surname>Lefevre</surname><given-names>T.</given-names></name><name><surname>Romano</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Transcatheter aortic valve replacement in the catheterization laboratory versus hybrid operating room: insights from the FRANCE TAVI registry</article-title><source>JACC Cardiovasc Interv</source><volume>11</volume><year>2018</year><fpage>2195</fpage><lpage>2203</lpage><pub-id pub-id-type="pmid">30409276</pub-id>
</element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Kiefer</surname><given-names>P.</given-names></name><name><surname>Gruenwald</surname><given-names>F.</given-names></name><name><surname>Kempfert</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Crimping may affect the durability of transcatheter valves: an experimental analysis</article-title><source>Ann Thorac Surg</source><volume>92</volume><year>2011</year><fpage>155</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">21718842</pub-id>
</element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Dapas</surname><given-names>J.I.</given-names></name><name><surname>Rivero</surname><given-names>C.</given-names></name><name><surname>Burgos</surname><given-names>P.</given-names></name><name><surname>Vila</surname><given-names>A.</given-names></name></person-group><article-title>Pseudomonas aeruginosa infective endocarditis following aortic valve implantation: a note of caution</article-title><source>Open Cardiovasc Med J</source><volume>10</volume><year>2016</year><fpage>28</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">27014375</pub-id>
</element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>McGiffin</surname><given-names>D.C.</given-names></name><name><surname>Kirklin</surname><given-names>J.K.</given-names></name></person-group><article-title>The impact of aortic valve homografts on the treatment of aortic prosthetic valve endocarditis</article-title><source>Semin Thorac Cardiovasc Surg</source><volume>7</volume><year>1995</year><fpage>25</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">7893834</pub-id>
</element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Kappetein</surname><given-names>A.P.</given-names></name><name><surname>Head</surname><given-names>S.J.</given-names></name><name><surname>Genereux</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document</article-title><source>Eur Heart J</source><volume>22</volume><year>2012</year><fpage>2403</fpage><lpage>2418</lpage></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Kuttamperoor</surname><given-names>F.</given-names></name><name><surname>Yandrapalli</surname><given-names>S.</given-names></name><name><surname>Siddhamsetti</surname><given-names>S.</given-names></name><name><surname>Frishman</surname><given-names>W.H.</given-names></name><name><surname>Tang</surname><given-names>G.H.L.</given-names></name></person-group><article-title>Infectious endocarditis after transcatheter aortic valve replacement: epidemiology and outcomes</article-title><source>Cardiol Rev</source><volume>27</volume><year>2019</year><fpage>236</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">31393286</pub-id>
</element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Habib</surname><given-names>G.</given-names></name><name><surname>Lancellotti</surname><given-names>P.</given-names></name><name><surname>Antunes</surname><given-names>M.J.</given-names></name><etal/></person-group><article-title>2015 ESC guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)</article-title><source>Eur Heart J</source><volume>36</volume><year>2015</year><fpage>3075</fpage><lpage>3128</lpage><pub-id pub-id-type="pmid">26320109</pub-id>
</element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Otto</surname><given-names>C.M.</given-names></name><name><surname>Nishimura</surname><given-names>R.A.</given-names></name><name><surname>Bonow</surname><given-names>R.O.</given-names></name><etal/></person-group><article-title>2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</article-title><source>J&#x000a0;Am Coll Cardiol</source><volume>77</volume><issue>4</issue><year>2021</year><fpage>e25</fpage><lpage>e197</lpage><pub-id pub-id-type="pmid">33342586</pub-id>
</element-citation></ref></ref-list><sec id="appsec1"><title>Appendix</title><p id="p0100">
<supplementary-material content-type="local-data" id="mmc1"><caption><title>Video 1</title><p>A 3-dimensional reconstruction video showing the transcatheter aortic valve replacement valve and the perivalvular mycotic abscess.</p></caption><media xlink:href="mmc1.mp4"/></supplementary-material>
<supplementary-material content-type="local-data" id="mmc2"><caption><title>Video 2</title><p>A transesophageal echocardiography video (left ventricular outflow tract axial) showing the transcatheter aortic valve replacement valve and the perivalvular mycotic abscess with multiple small hypodensities.</p></caption><media xlink:href="mmc2.mp4"/></supplementary-material>
<supplementary-material content-type="local-data" id="mmc3"><caption><title>Video 3</title><p>A transesophageal echocardiography video (left ventricular outflow tract long axis/5 chamber) of the transcatheter aortic valve replacement valve with the perivalvular mycotic abscess</p></caption><media xlink:href="mmc3.mp4"/></supplementary-material>
</p></sec><fn-group><fn id="d36e42"><p id="ntpara0015aa">The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors&#x02019; institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the <ext-link ext-link-type="uri" xlink:href="https://www.jacc.org/author-center" id="interref1">Author Center</ext-link>.</p></fn><fn id="appsec2"><p>Appendix</p><p id="p0105">For supplemental videos, please see the online version of this paper.</p></fn></fn-group></back></article>